Management ChangeApr 22, 2026, 04:32 PM
Quince Therapeutics Appoints June Bray as New Independent Director
AI Summary
Quince Therapeutics, Inc. announced the appointment of June Bray as a Class I independent director, effective April 22, 2026. This appointment increases the company's Board of Directors to four members. Ms. Bray will also serve on the Nominating & Governance, Audit, and Compensation Committees, receiving standard non-employee director compensation, including an annual retainer of $38,000 for board service and additional retainers for committee roles.
Key Highlights
- June Bray appointed as a Class I independent director.
- Board of Directors expanded to four members.
- Ms. Bray will serve on the Nominating & Governance, Audit, and Compensation Committees.
- Annual retainer for board service is $38,000.
- Additional annual retainers for committee service total $17,000.
Price Impact
More from QNCX